Quick Answer
Korro Bio, Inc. reported Earnings Per Share Diluted of $12.48 (loss) per share for the year ending 2025.
- Korro Bio, Inc. showed a decrease of -33.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Korro Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $0.55 (loss) per share | Q1 2023: $72.20 (loss) per share | Q2 2023: $63.83 (loss) per share | Q3 2023: $65.08 (loss) per share | Q1 2024: $2.44 (loss) per share | Q2 2024: $2.43 (loss) per share | Q3 2024: $2.26 (loss) per share | Q1 2025: $2.49 (loss) per share | Q2 2025: $2.74 (loss) per share | Q3 2025: $1.92 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), Korro Bio, Inc.'s Earnings Per Share Diluted has grown by 94.5%.
- Historical annual values: Fiscal year 2025: $12.48 (loss) per share | Fiscal year 2024: $9.37 (loss) per share | Fiscal year 2023: $53.08 (loss) per share | Fiscal year 2022: $227.42 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: